Epigral Q1 Results FY27: Date, Revenue Estimates and What to Expect

Get Free Investment Predictions and Epigral Research at Univest

Epigral is expected to announce its Q1 FY27 (April to June 2026) financial results in July or August 2026. This Epigral Q1 Results FY27 preview covers revenue prediction, Q1 expectations, key catalysts and risks, technical levels and the 12-month analyst price target.

India’s consumer goods and retail sector is navigating growth opportunities heading into Q1 Results FY27. The Epigral Q1 Results FY27 Q1 prediction and Q1 expectations will reflect these sector dynamics.

This Epigral Q1 Results FY27 Q1 result preview covers Q1 FY27 estimates, Q1 FY26 actual performance for context, key catalysts and risks, and the 12-month analyst price target.

About Epigral

Epigral Q1 Results FY27 will be a critical Q1 result preview for investors. Epigral is a consumer goods and retail company listed on the National Stock Exchange and Bombay Stock Exchange. Q1 FY27 (April to June 2026) results will be a key data point for assessing the full-year FY27 earnings trajectory. Any material beat or miss in the Epigral Q1 Results FY27 Q1 result preview will likely drive meaningful stock price movement.

Epigral reported Revenue of Rs.607 Cr in Q1 FY26, forming the year-on-year comparison base for the Epigral Q1 Results FY27 estimate. The Epigral Q1 Results FY27 Q1 expectations point to revenue of Rs.538-606 Cr.

Epigral Q1 FY27 Estimates: What to Expect

Epigral Q1 Results FY27 revenue prediction, PAT estimate, results date and 12-month analyst target.

Source: Q1 FY26 actuals from company filings. Epigral Q1 Results FY27 estimates (Q1 prediction) are Uniresearch trailing-growth projections. July 2026. Subject to change.

Key Catalysts to Watch in Epigral Q1 Results FY27

1. Urban Premiumisation and Volume Recovery

India’s urban middle class continues to trade up across FMCG categories, driving volume and mix improvement. Analysts will scrutinise management commentary on this point closely during the Epigral Q1 Results FY27 earnings call. This is a core Q1 prediction metric watched by investors.

2. Management Guidance for FY27

Full-year FY27 revenue and EBITDA margin guidance from the Epigral management team will be a key determinant of the stock’s reaction to Q1 Results FY27. Q1 expectations on guidance typically drive 60-70% of post-result price movement for consumer goods and retail companies.

3. Sector Macro Commentary

Management commentary on sector-specific dynamics including demand trends, input cost pressures, and competitive landscape will provide forward guidance visibility. This is one of the key Epigral Q1 Results FY27 Q1 expectations investors will monitor for sector direction.

Key Risks for Epigral Q1 Results FY27

• Raw material cost inflation in edible oils, packaging polymers, or food commodities can compress gross margins.
• Currency volatility and global macro uncertainty can impact revenue from export-facing business segments.
• Regulatory changes and compliance requirements can increase operating costs.

Track Epigral Q1 Results FY27 Fundamentals on Univest

Epigral Q1 FY26 Performance: Setting the Context

To understand Epigral Q1 Results FY27 Q1 expectations, it is important to contextualise Q1 FY26 (April to June 2025) performance. Epigral reported Q1 FY26 Revenue of Rs.607 Cr and PAT of Rs.161 Cr. This provides the year-on-year comparison base against which Epigral Q1 Results FY27 Q1 expectations will be assessed. Any material beat or miss in the Epigral Q1 Results FY27 Q1 result preview will likely drive meaningful stock price movement on results day.

Technical Analysis: Epigral Share Price Levels

• Epigral Q1 Results FY27: Current market price available on NSE portal
• For the latest 52-week high/low levels, track Epigral live on the NSE portal or Univest Screener
• Epigral Q1 Results FY27 Q1 expectations: Revenue in the Rs.538-606 Cr range
• The stock’s FY27 trajectory will be shaped by Epigral Q1 Results FY27 outcome and management guidance

Download the Univest iOS App or Univest Android App to track Epigral’s live price, charts and receive SEBI-backed research alerts.

Epigral Share Price Target: Analyst Estimates

Short-Term Target (3 to 6 Months)

In the near term, Epigral’s share price will be primarily driven by the Epigral Q1 Results FY27 outcome relative to estimates. A beat on Revenue or PAT, combined with positive management guidance for FY27, could drive the stock toward the higher end of analyst expectations. Analyst Q1 prediction: a beat on Epigral Q1 Results FY27 Revenue or PAT could drive the stock higher.

12-Month Target (Uniresearch Estimate)

The Epigral Q1 Results FY27 12-month price target is estimated at available on the Univest research platform. This is contingent on Epigral Q1 Results FY27 meeting Q1 expectations and FY27 guidance being constructive.

Long-Term View (FY27 to FY28)

Longer-term, the Epigral Q1 Results FY27 Q1 result preview will anchor the FY27-FY28 outlook. Longer-term, Epigral’s share price trajectory will depend on sector growth trends, market share dynamics, management execution quality, and India’s overall macroeconomic environment.

What to Watch on Epigral Q1 Results FY27 Day

• Epigral Q1 Results FY27 Revenue and PAT numbers relative to Q1 Results FY27 estimates of Rs.538-606 Cr Revenue
• Epigral Q1 Results FY27 management guidance: full-year FY27 Revenue and EBITDA margin direction
• Epigral Q1 Results FY27 sector-specific operating metrics: urban premiumisation and volume recovery and management guidance
• Any dividend announcement or capital allocation guidance
• Management commentary on macro headwinds including Raw material cost inflation in edible oils, packaging polymers, or food commodit

Conclusion

Epigral Q1 Results FY27 is one of the key Q1 result preview events for India’s consumer goods and retail sector in the July-August 2026 results season. This Epigral Q1 Results FY27 Q1 result preview is anchored on Q1 expectations of Rs.538-606 Cr Revenue. Monitor the Univest research platform for Epigral Q1 Results FY27 real-time commentary, Q1 predictions and Q1 expectations post the Q1 result preview declaration.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a stock recommendation. All estimates, analyst targets, and financial projections are based on Uniresearch trailing-growth analysis and are subject to change. Investing in stocks involves market risk. Please consult a SEBI-registered financial advisor before making any investment decision. SEBI RA INH000013776.

Frequently Asked Questions on Epigral Q1 Results FY27

When is Epigral Q1 FY27 results date?

Ans. The Epigral Q1 FY27 results date has not been officially announced yet. Q1 FY27 (April to June 2026) results are typically declared in July or August 2026. Check the NSE or BSE filing portal for the exact Epigral Q1 Results FY27 results date.

What is the Epigral Q1 FY27 revenue estimate?

Ans. The Epigral Q1 Results FY27 revenue prediction (Q1 FY27 estimate) based on Uniresearch trailing-growth analysis is Rs.538 to Rs.606 Cr. Actual Q1 Results FY27 revenue may differ from this Q1 prediction.

What is the Epigral share price target?

Ans. The Epigral Q1 Results FY27 12-month price target is available on the Univest research platform. Targets are subject to revision based on Q1 Results FY27 outcome.

Is Epigral a good buy before Q1 FY27 results?

Ans. Investing ahead of Epigral Q1 Results FY27 carries earnings risk. Q1 expectations and Q1 predictions vary, and quarterly results can cause sharp price moves. Assess whether Epigral offers a good risk-reward at current levels relative to Q1 result preview scenarios. Consult a SEBI-registered financial advisor before any investment decision.

What should I watch for in Epigral Q1 FY27 results?

Ans. Key metrics to monitor for Epigral Q1 Results FY27 results: Revenue performance versus the Q1 prediction of Rs.538-606 Cr; PAT versus estimate; management guidance for FY27; urban premiumisation and volume recovery progress; and management commentary on macro headwinds including Raw material cost inflation in edible oils, packaging polymers, or food commodit.

Where can I find Epigral Q1 FY27 results?

Ans. Epigral Q1 Results FY27 will be available on the BSE (bseindia.com) and NSE (nseindia.com) filing portals immediately after the board meeting. For real-time analysis, expert commentary, and updated Epigral Q1 Results FY27 Q1 prediction and Q1 expectations analysis after results are declared, download the Univest app.